177 related articles for article (PubMed ID: 35845489)
1. Seronegative rheumatic arthritis has milder inflammation and bone erosion in an ultrasound study of disease-modifying anti-rheumatic drugs (DMARDs)-naïve Chinese cohort.
Lin D; Zhao M; Zhang Y; Xie Y; Cao J; Pan Y
Ann Transl Med; 2022 Jun; 10(12):661. PubMed ID: 35845489
[TBL] [Abstract][Full Text] [Related]
2. Presence of power Doppler synovitis in rheumatoid arthritis patients with synthetic and/or biological disease-modifying anti-rheumatic drug-induced clinical remission: experience from a Chinese cohort.
Geng Y; Han J; Deng X; Zhang Z
Clin Rheumatol; 2014 Aug; 33(8):1061-6. PubMed ID: 24777468
[TBL] [Abstract][Full Text] [Related]
3. Patients with seronegative RA have more inflammatory activity compared with patients with seropositive RA in an inception cohort of DMARD-naïve patients classified according to the 2010 ACR/EULAR criteria.
Nordberg LB; Lillegraven S; Lie E; Aga AB; Olsen IC; Hammer HB; Uhlig T; Jonsson MK; van der Heijde D; Kvien TK; Haavardsholm EA;
Ann Rheum Dis; 2017 Feb; 76(2):341-345. PubMed ID: 27094444
[TBL] [Abstract][Full Text] [Related]
4. [The correlation study on syndrome differentiation of rheumatoid arthritis and joint high frequency ultrasound performance].
Bi YN; Xiao CH; Pan C; Zhao XF; Cao YY; Yuan Yi ; Zuo FF
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Jan; 35(1):19-24. PubMed ID: 25790669
[TBL] [Abstract][Full Text] [Related]
5. [Relationship between wrist bone mineral density and synovitis, erosion by ultrasonography in female rheumatoid arthritis patients].
Wang Y; Geng Y; Deng XR; Zhang ZL
Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Oct; 47(5):774-80. PubMed ID: 26474614
[TBL] [Abstract][Full Text] [Related]
6. Anticollagen type II antibodies are associated with an acute onset rheumatoid arthritis phenotype and prognosticate lower degree of inflammation during 5 years follow-up.
Manivel VA; Mullazehi M; Padyukov L; Westerlind H; Klareskog L; Alfredsson L; Saevarsdottir S; Rönnelid J
Ann Rheum Dis; 2017 Sep; 76(9):1529-1536. PubMed ID: 28336519
[TBL] [Abstract][Full Text] [Related]
7. Subclinical inflammation on MRI of hand and foot of anticitrullinated peptide antibody-negative arthralgia patients at risk for rheumatoid arthritis.
van Steenbergen HW; van Nies JA; Huizinga TW; Reijnierse M; van der Helm-van Mil AH
Arthritis Res Ther; 2014 Apr; 16(2):R92. PubMed ID: 24721160
[TBL] [Abstract][Full Text] [Related]
8. Rheumatoid Arthritis Patients With Circulating Extracellular Vesicles Positive for IgM Rheumatoid Factor Have Higher Disease Activity.
Arntz OJ; Pieters BCH; Thurlings RM; Wenink MH; van Lent PLEM; Koenders MI; van den Hoogen FHJ; van der Kraan PM; van de Loo FAJ
Front Immunol; 2018; 9():2388. PubMed ID: 30420853
[TBL] [Abstract][Full Text] [Related]
9. Missing Anticitrullinated Protein Antibody Does Not Affect Short-term Outcomes in Early Inflammatory Arthritis: From the Canadian Early Arthritis Cohort.
Shu J; Bykerk VP; Boire G; Haraoui B; Hitchon C; Thorne JC; Tin D; Keystone EC; Pope JE;
J Rheumatol; 2015 Nov; 42(11):2023-8. PubMed ID: 26329342
[TBL] [Abstract][Full Text] [Related]
10. Differing X-ray patterns in seronegative and seropositive rheumatoid arthritis.
Gadeholt O; Hausotter K; Eberle H; Klink T; Pfeil A
Clin Rheumatol; 2019 Sep; 38(9):2403-2410. PubMed ID: 31123977
[TBL] [Abstract][Full Text] [Related]
11. Patients with seronegative rheumatoid arthritis have a different phenotype than seropositive patients: A clinical and ultrasound study.
Carbonell-Bobadilla N; Soto-Fajardo C; Amezcua-Guerra LM; Batres-Marroquín AB; Vargas T; Hernández-Diazcouder A; Jiménez-Rojas V; Medina-García AC; Pineda C; Silveira LH
Front Med (Lausanne); 2022; 9():978351. PubMed ID: 36052337
[TBL] [Abstract][Full Text] [Related]
12. Hypogalactosylation of immunoglobulin G in rheumatoid arthritis: relationship to HLA-DRB1 shared epitope, anticitrullinated protein antibodies, rheumatoid factor, and correlation with inflammatory activity.
Schwedler C; Häupl T; Kalus U; Blanchard V; Burmester GR; Poddubnyy D; Hoppe B
Arthritis Res Ther; 2018 Mar; 20(1):44. PubMed ID: 29540200
[TBL] [Abstract][Full Text] [Related]
13. Characterization of cumulative joint damage patterns in patients with rheumatoid arthritis: a clinical, serological, and gene polymorphism perspective.
Alarcon RT; Fernandes Ada R; Laurindo IM; Bértolo MB; Pinheiro GC; Andrade LE
J Rheumatol; 2015 Mar; 42(3):405-12. PubMed ID: 25641888
[TBL] [Abstract][Full Text] [Related]
14. Importance of baseline musculoskeletal ultrasound findings in the prognosis of rheumatoid arthritis.
Sun C; Qi X; Yang Y; Lei L; Gao L; Guo H
Clin Rheumatol; 2022 Mar; 41(3):847-857. PubMed ID: 35041111
[TBL] [Abstract][Full Text] [Related]
15. Short-term outcome after anti-tumor necrosis factor-alpha therapy in rheumatoid arthritis: do we need to revise our assessment criteria?
El Miedany Y; Youssef SS; El Gaafary M
J Rheumatol; 2006 Mar; 33(3):490-7. PubMed ID: 16511918
[TBL] [Abstract][Full Text] [Related]
16. Joint damage is amplified in rheumatoid arthritis patients with positive thyroid autoantibodies.
Chen YL; Lin JZ; Mo YQ; Liang JJ; Li QH; Zhou CJ; Wei XN; Ma JD; Yang ZH; Zheng DH; Dai L
PeerJ; 2018; 6():e4216. PubMed ID: 29312834
[TBL] [Abstract][Full Text] [Related]
17. The universal presence of poor prognostic factors based on EULAR recommendations: A real-world study in 1164 Chinese RA patients.
Gui Y; Zhao J; Xie W; Huang H; Zhang Z
Joint Bone Spine; 2023 Dec; 90(6):105633. PubMed ID: 37684001
[TBL] [Abstract][Full Text] [Related]
18. MRI evidence of persistent joint inflammation and progressive joint damage despite clinical remission during treatment of early rheumatoid arthritis.
Forslind K; Svensson B
Scand J Rheumatol; 2016; 45(2):99-102. PubMed ID: 26313244
[TBL] [Abstract][Full Text] [Related]
19. Gray Scale and Power Doppler Ultrasonographic Findings in the Assessment of Disease Activity and Their Correlation with Disease Activity Parameters in Rheumatoid Arthritis.
Jindal S; Kaushik R; Raghuvanshi S; Kaushik RM; Kakkar R
Curr Rheumatol Rev; 2018; 14(2):153-162. PubMed ID: 28117013
[TBL] [Abstract][Full Text] [Related]
20. Rituximab for refractory rheumatoid arthritis: a 24-week open-label prospective study.
Ho LY; Mok CC; To CH; Anselm M; Cheung MY; Yu KL
Open Rheumatol J; 2007; 1():1-4. PubMed ID: 19088893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
